Treatment with the PI3K inhibitor buparlisib (NVP-BKM120) suppresses the growth of established patient-derived GBM xenografts and prolongs survival in nude rats
使用 PI3K 抑制剂 buparlisib (NVP-BKM120) 治疗可抑制已建立的患者来源的 GBM 异种移植瘤的生长并延长裸鼠的生存期
期刊:Journal of Neuro-Oncology
影响因子:3.2
doi:10.1007/s11060-016-2158-1
I A Netland, H E Førde, L Sleire, L Leiss, M A Rahman, B S Skeie, H Miletic, P Ø Enger, D Goplen
